Royce Micro-Cap Trust advanced 16.6% on a net asset value basis and 16.1% on a market price basis in 2025, outpacing its ...
Q4 2025 Management View CEO Joseph Burnett stated that ClearPoint Neuro ended 2025 on its strongest financial quarter of the year, highlighting "a newly acquired and commercialized neurocritical care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results